Cushing’s Syndrome: Symptoms, Causes, and Treatment Options

Cushing’s Syndrome: Symptoms, Causes, and Treatment Options


Highlights on Cushing’s Syndrome

  1. Cushing’s syndrome is a hormonal disorder caused by excessive cortisol in the body, with the most common cause being prolonged use of corticosteroids.
  2. The two tell-tale signs are moon face and buffalo hump, which arise due to fat redistribution caused by high cortisol levels.
  3. Cushing’s syndrome can cause mood swings, irritability, anxiety, and depression. In severe cases, it may even lead to cognitive decline or psychosis.
  4. Cushing’s disease is a type of Cushing’s syndrome caused due to the excess production of cortisol because of a pituitary tumor.
  5. There is a strong link between Cushing’s syndrome and diabetes, osteoporosis, and metabolic syndrome.

What is Cushing’s Syndrome?

Cushing’s syndrome occurs when the body is exposed to high levels of the hormone cortisol for an extended period. This can result from prolonged use of corticosteroid medications or, less commonly, from the body producing excess cortisol due to a tumor in the pituitary gland (Cushing’s disease), adrenal glands, or other body parts.

Typically, cortisol, a stress hormone, is produced from adrenal glands located on the top of each kidney. Cortisol is responsible for the flight and fight response. But when high, it causes Cushing’s syndrome. The annual incidence of Cushing’s syndrome ranges from 1.8 to 3.2 cases per million population.

Causes of Cushing’s Syndrome

Some of the common causes of cushing’s syndrome are:

cushing's syndrome causes

1. Long-Term Use of Steroid Medications

This is the most common cause. If you take corticosteroid medications like prednisone for a long time, it can cause your body to have high levels of cortisol. These drugs often treat conditions like asthma, arthritis, or lupus. While they help control these illnesses, long-term use can lead to Cushing’s syndrome.

2. Cushing’s Disease

Sometimes, a small tumor can grow on your pituitary gland, which is located at the base of your brain. This tumor can cause your body to produce too much of a hormone called Adrenocorticotrophic Hormone (ACTH), which in turn causes your adrenal glands to produce more cortisol. This is the most common cause of Cushing’s syndrome when it happens naturally in the body and is called Cushing’s disease. It makes up about 60-70% of the cases.

3. Adrenal Gland Tumors

Your adrenal glands can develop a tumor that directly produces extra cortisol. These tumors are usually not cancerous, but they can still cause your cortisol levels to spike. These benign tumors account for 0.6 million of the yearly incidence of Cushing’s syndrome. 

4. Ectopic ACTH Syndrome

In rare cases, tumors in other parts of your body, like your lungs or pancreas, can produce ACTH. This is called ectopic ACTH syndrome, as it is made outside of the body’s normal control system. These tumors are usually cancerous and cause your adrenal glands to make more cortisol, causing Cushing’s syndrome.

Symptoms of Cushing’s Syndrome

The most common symptoms of cushing’s syndrome are:

cushing's syndrome symptoms

1. Weight Gain

Too much cortisol in your body makes your body produce and store fat differently. You’ll notice that you gain weight mostly around your belly, face, and upper back, giving you a rounded face called moon face and a hump on your upper back called buffalo hump. You will probably start to see these changes slowly, with your face and trunk getting bigger first.

2. Thin Skin

Excess cortisol in your body can make your skin thin and make it easy to bruise. It stops cells from making collagen, weakens blood vessels, and delays the healing of wounds. If you notice that you bruise easily, along with other skin changes like purple stretch marks and thinning skin, it could be a sign of Cushing’s syndrome.

3. Muscle Weakness

In Cushing’s syndrome, your muscles weaken because high cortisol levels break down muscle proteins and prevent new ones from forming. This can even make it difficult for you to climb stairs, get up from chairs, or lift things easily.

4. Bone Loss

An increased risk of fractures results from bone loss. It may have an overall sense of being poorly or feeling exhausted all the time. According to the 50% prevalence of osteoporosis, between 30 and 50 percent of individuals with CS suffer fractures, especially at the spinal level.

5. High Blood Pressure

High cortisol levels in the body cause your kidneys to retain salt and water and raise the blood pressure.

6. Mood Changes

Many people with this condition experience mood swings, irritability, and anxiety. Depression is particularly common, often presenting as persistent sadness, lack of interest in activities, and feelings of hopelessness. Some individuals may develop more severe psychiatric conditions, such as memory problems or cognitive decline. Sleep disturbances are also common, which can worsen feelings of fatigue and emotional instability. In rare cases, high cortisol can lead to psychosis, where individuals may experience hallucinations or delusions.

Diagnosis of Cushing’s Syndrome

The diagnosis of cushing’s syndrome is made with the following tests:

cushing's syndrome diagnosis

Laboratory Tests

1. 24-Hour Urinary Free-Cortisol Tests

In this test, you’ll collect your urine over a 24-hour period. The sample is then checked to see how much cortisol is in it. High cortisol levels in your urine can point to Cushing’s syndrome.

2. Late-Night Salivary Cortisol Test

This test measures cortisol in your saliva late in the evening. Normally, cortisol drops after you fall asleep, but in Cushing’s syndrome, it doesn’t. You can collect your saliva sample at home and send it to a lab.

3. Dexamethasone Suppression Test

This is an important tool used to diagnose Cushing’s syndrome, and there are two types.

  • Low-Dose Dexamethasone Suppression Test: This test confirms whether your body is producing too much cortisol. You’ll take a small dose of dexamethasone, a synthetic steroid, usually at night (1 mg around 11 PM). The next morning, your blood is tested to check your cortisol levels. In a normal response, dexamethasone suppresses the production of cortisol by the adrenal glands. If your cortisol levels remain high, it suggests that your body is not properly regulating cortisol, which can indicate Cushing’s syndrome.
  • High-Dose Dexamethasone Suppression Test: If the low-dose test indicates that you may have Cushing’s syndrome, the high-dose test is used to figure out the cause. For this test, you’ll take a higher dose of dexamethasone (8 mg) the night before, and your cortisol levels are measured the next morning. If the cortisol levels drop significantly, it usually means the cause is a pituitary tumor. If cortisol levels stay high, it might be caused by an adrenal tumor or ectopic ACTH-producing tumor.

4. Imaging Tests

If the other tests suggest Cushing’s syndrome, imaging tests like a CT scan of the chest or MRI of the brain may be used to look for tumors in your pituitary or adrenal glands, which could be causing the excess cortisol.

Treatment of Cushing’s Syndrome

Cushing’s syndrome treatment options:

cushing's syndrome treatment

1. Reducing Corticosteroid Use

If the syndrome is due to long-term medication use, your doctor will gradually lower your dosage or switch medications.

2. Surgery

If Cushing’s syndrome is caused by a tumor, the most effective treatment is often surgical removal of the tumor. For pituitary tumors, this typically involves transsphenoidal surgery, where the tumor is accessed through the nose. If the tumor is in the adrenal gland, it may require laparoscopic surgery. In cases of ectopic ACTH syndrome, the tumor causing excess ACTH secretion is removed when possible. Temporary or life-long cortisol replacement therapy may be needed after surgery.

3. Radiation Therapy

If surgery isn’t an option or is unsuccessful, radiation therapy may be used, either over several weeks or as a single high-dose treatment. This is more common for pituitary tumors. It can help shrink the tumor over time and lower cortisol production. Cortisol levels may take years to normalize after radiation so medications may be prescribed in the interim.

4. Medications

Several medications can help control cortisol production or control symptoms if surgery and radiation aren’t suitable.

  • Drugs Inhibiting Cortisol Production:  Several medications are available to manage Cushing’s syndrome, each targeting cortisol production in different ways. These include ketoconazole, metyrapone, osilodrostat, mitotane, and etomidate. Ketoconazole blocks enzymes involved in cortisol synthesis but may pose a risk of liver damage.Etomidate is used intravenously for rapid control of severe hypercortisolism during emergencies.
  • Drugs for The Pituitary Gland: Pasireotide targets pituitary tumors to reduce ACTH and cortisol levels. Cabergoline can effectively control ACTH secretion alone or in combination with other drugs.
  • Mifepristone: This medication blocks glucocorticoid receptors, helping to control high blood sugar and other metabolic issues of Cushing’s syndrome. While it doesn’t lower cortisol levels, it reduces the impact of cortisol on the body.

5. Lifestyle Modifications

Alongside medical treatments, lifestyle changes can help manage symptoms. This may include a healthy diet, regular exercise, salt restriction if you have high blood pressure, and stress management techniques to improve overall well-being and help combat the effects of high cortisol.

Complications of Cushing’s Syndrome

Cushing’s syndrome comes with several complications due to long-term high cortisol levels. These include:

cushing's syndrome complications

1. Type 2 Diabetes

The link between Cushing’s syndrome and Type 2 Diabetes Mellitus lies in the role of cortisol in glucose metabolism. In Cushing’s Syndrome, elevated cortisol levels trigger increased glucose production, insulin resistance, and impaired insulin secretion.

2. Metabolic Complications

Cushing’s syndrome often causes metabolic syndrome, with symptoms like obesity, high blood pressure, abnormal cholesterol levels, and glucose problems, including diabetes. These issues raise the risk of heart problems like heart attacks and strokes.

3. Musculoskeletal Problems

Patients often have weak muscles and fragile bones, leading to a higher risk of fractures, especially in the spine.

4. Cardiovascular Risks

High blood pressure, which is common in Cushing’s syndrome, increases the chances of heart issues and death from heart-related problems. Cushing’s syndrome also raises the risk of blood clots, increasing the likelihood of strokes and other clot-related issues.

5. Immune System Weakness

Chronic high cortisol weakens the immune system, making people more prone to infections. This can lead to severe infections and even life-threatening conditions like sepsis.

6. Osteoporosis

In Cushing’s syndrome, excessive cortisol weakens your bones by slowing down bone formation, accelerating bone breakdown, disrupting calcium regulation, and causing hormonal imbalances. This can result in weaker bones and a higher risk of fractures despite appearing strong. Additionally, excess fat in bones and blood sugar issues further contribute to bone weakening.

7. Excess Hair Growth

Excessive hair growth in Cushing’s syndrome results from the overproduction of adrenal androgens, particularly in ACTH-dependent forms of the disease. This leads to hirsutism, a common manifestation in Cushing’s Syndrome patients.

8. Reproductive and Sexual Issues

High cortisol levels can disrupt menstrual cycles, cause infertility, impaired spermatogenesis, and lower sex drive by affecting reproductive organs and hormone levels.

Questions to ask your Doctor

  1. What symptoms should I watch for that might indicate my condition is worsening?
  2. How will my treatment affect my daily life?
  3. What is the prognosis with treatment?
  4. How often will I need follow-up appointments, and what will they involve?
  5. If I have Cushing’s syndrome, is my child at risk of developing it?

References

  1. Lindholm J, Juul S, Jørgensen JOL, Astrup J, Bjerre P, Feldt-Rasmussen U, et al. Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study 1. J Clin Endocrinol Metab 2001;86:117–23. https://doi.org/10.1210/jcem.86.1.7093
  2. Reincke M, Fleseriu M. Cushing Syndrome. JAMA 2023;330:170. https://doi.org/10.1001/jama.2023.11305
  3. Williams DM. Clinical Pharmacology of Corticosteroids. Respir Care 2018;63:655–70. https://doi.org/10.4187/respcare.06314
  4. Isales CM, Zaidi M, Blair HC. ACTH is a novel regulator of bone mass. Ann N Y Acad Sci 2010;1192:110–6. https://doi.org/10.1111/j.1749-6632.2009.05231.x.
  5. Steffensen C, Bak AM, Zøylner Rubeck K, Jørgensen JOL. Epidemiology of Cushing’s Syndrome. Neuroendocrinology 2010;92:1–5. https://doi.org/10.1159/000314297
  6. Bavaresco A, Mazzeo P, Lazzara M, Barbot M. Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us? Biochem Pharmacol 2024;223:116137. https://doi.org/10.1016/j.bcp.2024.116137
  7. Stratakis CA. Skin manifestations of Cushing’s syndrome. Rev Endocr Metab Disord 2016;17:283–6. https://doi.org/10.1007/s11154-016-9399-3
  8. Minetto MA, Lanfranco F, Botter A, Motta G, Mengozzi G, Giordano R, et al. Do muscle fiber conduction slowing and decreased levels of circulating muscle proteins represent sensitive markers of steroid myopathy? A pilot study in Cushing’s disease. Eur J Endocrinol 2011;164:985–93. https://doi.org/10.1530/eje-10-1169
  9. Rahaman SH, Jyotsna VP, Kandasamy D, Shreenivas V, Gupta N, Tandon N. Bone Health in Patients with Cushing’s Syndrome. Indian J Endocrinol Metab 2018;22:766–9. https://doi.org/10.4103/ijem.IJEM_160_18
  10. Magiakou MA, Smyrnaki P, Chrousos GP. Hypertension in Cushing’s syndrome. Best Practice & Research Clinical Endocrinology & Metabolism 2006;20:467–82. https://doi.org/10.1016/j.beem.2006.07.006
  11. Santos A, Webb SM, Resmini E. Psychological complications of Cushing’s syndrome. Curr Opin Endocrinol Diabetes Obes 2021;28:325–9. https://doi.org/10.1097/MED.0000000000000633
  12. Savas M, Mehta S, Agrawal N, van Rossum EFC, Feelders RA. Approach to the Patient: Diagnosis of Cushing Syndrome. J Clin Endocrinol Metab 2022;107:3162–74. https://doi.org/10.1210/clinem/dgac492
  13. Wright K, van Rossum EFC, Zan E, Werner N, Harris A, Feelders RA, et al. Emerging diagnostic methods and imaging modalities in cushing’s syndrome. Front Endocrinol (Lausanne) 2023;14. https://doi.org/10.3389/fendo.2023.1230447
  14. Honegger J, Nasi‐Kordhishti I. Surgery and perioperative management of patients with Cushing’s disease. J Neuroendocrinol 2022;34. https://doi.org/10.1111/jne.13177
  15. Lian X, Xu Z, Sun S, Wang W, Zhu H, Lu L, et al. Intensity-modulated radiotherapy for cushing’s disease: single-center experience in 70 patients. Front Endocrinol (Lausanne) 2023;14. https://doi.org/10.3389/fendo.2023.1241669
  16. Carroll TB, Peppard WJ, Herrmann DJ, Javorsky BR, Wang TS, Patel H, et al. Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol. J Endocr Soc 2018;3:1–12. https://doi.org/10.1210/js.2018-00269
  17. Pivonello R, De Leo M, Cozzolino A, Colao A. The Treatment of Cushing’s Disease. Endocr Rev 2015;36:385–486. https://doi.org/10.1210/er.2013-1048
  18. Molitch ME. Glucocorticoid receptor blockers. Pituitary 2022;25:733–6. https://doi.org/10.1007/s11102-022-01227-x
  19. Varlamov E V, Langlois F, Vila G, Fleseriu M. MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing’s syndrome: a practical approach. Eur J Endocrinol 2021;184:R207–24. https://doi.org/10.1530/EJE-20-1309
  20. Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BMK, Colao A. Complications of Cushing’s syndrome: state of the art. Lancet Diabetes Endocrinol 2016;4:611–29. https://doi.org/10.1016/S2213-8587(16)00086-3
  21. Hasenmajer V, Sbardella E, Sciarra F, Minnetti M, Isidori AM, Venneri MA. The Immune System in Cushing’s Syndrome. Trends in Endocrinology & Metabolism 2020;31:655–69. https://doi.org/10.1016/j.tem.2020.04.004
  22. Godang K, Ueland T, Bollerslev J. Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing’s syndrome. Eur J Endocrinol 1999:126–31. https://doi.org/10.1530/eje.0.1410126
  23. Kaltsas G, Makras P. Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy. Neuroendocrinology 2010;92:60–4. https://doi.org/10.1159/000314298
  24. Livia Gheorghiu M, Fleseriu M. Conundrums of Diagnosis and Management of Cushing’s Syndrome in Pregnancy. Endocrinol Metab Clin North Am 2024;53:421–35. https://doi.org/10.1016/j.ecl.2024.05.007

Most Popular